Stay updated on Savolitinib for MET Amplified Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page.

Latest updates to the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page
- ChecktodayChange DetectedA site-wide banner announces updates and FAQs about NIH website changes, including a notice about terminology shifting from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check7 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2 while the page continues to show a 403 error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now displays a 403 Forbidden error, signaling restricted access to the study record. The header shows a minimal navigation with a Home link and a revision note, replacing the previously accessible study content.SummaryDifference19%

- Check56 days agoChange DetectedThe page's revision label was updated to v3.6.6, signaling a small backend or display framework update. This change does not modify the study content or user-facing information.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision: v3.6.5 was added, replacing Revision: v3.6.4. This indicates a minor site version update and does not modify the study details or how the page functions.SummaryDifference0.0%

Stay in the know with updates to Savolitinib for MET Amplified Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page.